V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011301 | 280012025 | 1.75 | 54 | Palliative (P) | 2014-01-19 | 2014-04-06 | VAI (Ifos 3g/m2) | 1 | N | 280028921 | IRINOTECAN + TEMOZOLOMIDE |
| 280011302 | 280011395 | null | 66.5 | Curative (C) | 2016-04-22 | 2016-06-14 | Doxorubicin + Ifosfamide | 2 | N | 280028929 | DOXORUBICIN + IFOSFAMIDE |
| 280011303 | 280006046 | 1.58 | 46.6 | Curative (C) | 2016-01-13 | 2018-01-12 | CISPLATIN + FLUOROURACIL | N | N | 280028950 | CISPLATIN + FLUOROURACIL |
| 280011304 | 280006053 | 1.85 | null | Palliative (P) | 2017-01-03 | 2017-01-21 | Etoposide + Ifosfamide (5 days) | null | null | 280028989 | ETOPOSIDE + IFOSFAMIDE |
| 280011305 | 280009174 | 1.79 | 65.9 | Palliative (P) | 2016-10-13 | 2016-10-14 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280029001 | CISPLATIN + GEMCITABINE |
| 280011306 | 280006060 | 1.74 | 68.5 | Palliative (P) | 2018-04-29 | 2018-05-13 | Etoposide + Ifosfamide (3 days) | N | N | 280029009 | ETOPOSIDE + IFOSFAMIDE |
| 280011307 | 280006066 | 1.86 | 64 | Palliative (P) | 2016-04-10 | 2016-09-03 | DE-ESCALATE TRIAL | 02 | N | 280029015 | DE-ESCALATE TRIAL |
| 280011308 | 280006072 | 1.66 | 94 | Palliative (P) | 2016-11-23 | 2016-12-05 | VAC | null | null | 280029021 | CAV |
| 280011309 | 280006077 | 1.8 | 78 | Palliative (P) | 2016-10-31 | 2017-03-21 | Etoposide + Ifosfamide (3 days) | N | N | 280029044 | ETOPOSIDE + IFOSFAMIDE |
| 280011310 | 280009185 | 1.65 | null | Neo-adjuvant (N) | 2015-06-25 | 2015-06-26 | CISPLATIN + FLUOROURACIL | 02 | N | 280029057 | CISPLATIN + FLUOROURACIL |
| 280011311 | 280006088 | null | 69.2 | Palliative (P) | 2014-07-09 | 2014-08-29 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 280029070 | CISPLATIN + GEMCITABINE |
| 280011312 | 280009189 | 1.7 | 66.2 | Adjuvant (A) | 2018-07-16 | 2018-07-25 | CYCLOPHOSPHAMIDE | N | N | 280029081 | CYCLOPHOSPHAMIDE |
| 280011313 | 280006093 | null | null | Palliative (P) | null | 2016-06-13 | Doxorubicin + Ifosfamide | null | null | 280029090 | DOXORUBICIN + IFOSFAMIDE |
| 280011314 | 280006096 | null | null | null | 2018-06-19 | 2018-07-04 | Oxaliplatin + Modified de Gramont | N | N | 280029095 | OXALIPLATIN + MDG |
| 280011315 | 280011405 | 1.65 | 67.4 | Palliative (P) | null | 2018-01-10 | Etoposide + Ifosfamide (3 days) | null | null | 280029101 | ETOPOSIDE + IFOSFAMIDE |
| 280011316 | 280006098 | 1.76 | 50.5 | Curative (C) | null | 2017-03-01 | AFLIBERCEPT + FU + IRINOTECAN | 2 | N | 280029106 | CARBOPLATIN + LIPOSOMAL DOX |
| 280011317 | 280006100 | 1.8 | 92 | Curative (C) | 2016-08-24 | 2016-08-24 | VIDE | 2 | N | 280029116 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280011318 | 280006102 | 1.84 | 53.8 | Adjuvant (A) | 2017-05-07 | 2017-06-08 | Epirubicin (weekly) | N | N | 280029119 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280011319 | 280006104 | 1.76 | 68.4 | Palliative (P) | 2015-09-09 | 2015-11-05 | NIVOLUMAB | 02 | N | 280029120 | CISPLATIN + FLUOROURACIL + RT |
| 280011320 | 280006113 | 0 | 66.4 | Palliative (P) | 2014-05-14 | 2014-05-17 | INTERFERON | 02 | null | 280029152 | IVADO |
| 280011321 | 280009206 | null | 63.75 | Curative (C) | 2017-05-31 | 2017-05-31 | IVADo | 99 | N | 280029169 | CAPECITABINE + CISPLATIN |
| 280011322 | 280009207 | 1.82 | 68.4 | Curative (C) | 2014-05-30 | 2014-05-30 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | 280029172 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280011323 | 280006128 | 1.55 | 79.5 | Palliative (P) | 2018-05-01 | 2018-05-01 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280029210 | CARBO + FLUOROURACIL |
| 280011324 | 280006131 | 1.69 | 66.2 | Disease modification (D) | 2014-03-16 | 2014-03-17 | VIDE | 02 | N | 280029221 | VIDE |
| 280011325 | 280006133 | 1.8 | 60.8 | Neo-adjuvant (N) | 2016-05-03 | 2016-06-18 | Capecitabine + Oxaliplatin 21day | 2 | N | 280029255 | CYCLOPHOSPHAMIDE + DOXORUBICIN |
| 280011326 | 280006142 | 1.67 | 65.85 | Palliative (P) | 2016-02-24 | 2016-04-23 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 280029293 | METHOTREXATE |
| 280011327 | 280006147 | 1.7 | 61.5 | Neo-adjuvant (N) | 2016-05-04 | 2016-05-10 | LANREOTIDE | N | N | 280029309 | BUSULFAN + MELPHALAN |
| 280011328 | 280006149 | 1.88 | 75.6 | Palliative (P) | 2018-10-28 | 2018-10-29 | BCG Intravesical | N | N | 280029313 | VIDE |
| 280011329 | 280009224 | 0 | 70.6 | null | 2017-05-03 | 2017-05-09 | LANREOTIDE | N | N | 280029327 | CARBO + FLUOROURACIL |
| 280011330 | 280009224 | 1.8 | 89.8 | Palliative (P) | 2015-12-04 | 2016-01-15 | CASPS TRIAL | Y | N | 280029327 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280011331 | 280006158 | 1.74 | 77.8 | Palliative (P) | 2016-10-07 | 2017-10-28 | DACTINOMYCIN + CYCLO + VINCRISTINE | N | N | 280029362 | CHOP R |
| 280011332 | 280006159 | 1.81 | 88 | Palliative (P) | 2016-06-19 | 2016-06-24 | Everolimus 10mg | N | N | 280029366 | VINORELBINE |
| 280011333 | 280006162 | 1.85 | 83.95 | Adjuvant (A) | 2015-09-21 | 2015-10-18 | Panitumumab | 02 | N | 280029380 | VINORELBINE |
| 280011334 | 280006164 | 1.66 | null | Neo-adjuvant (N) | 2016-02-11 | 2016-10-05 | CARBOPLATIN + FLUOROURACIL | N | Y | 280029388 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280011335 | 280006167 | null | 105.9 | Curative (C) | 2017-08-09 | 2017-08-09 | Gemcitabine + Capecitabine | N | Y | 280029389 | EOX |
| 280011336 | 280006170 | null | 92.7 | Adjuvant (A) | 2015-05-03 | 2015-05-21 | IVADo | 02 | N | 280029418 | CAPECITABINE + OXALIPLATIN |
| 280011337 | 280006172 | 1.78 | 61.3 | Palliative (P) | 2017-10-09 | 2017-10-09 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 2 | N | 280029421 | DOCETAXEL |
| 280011338 | 280006182 | 1.64 | 54.8 | Palliative (P) | 2018-05-05 | 2018-05-28 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 01 | N | 280029438 | PEMBROLIZUMAB |
| 280011339 | 280009239 | null | null | Neo-adjuvant (N) | 2014-03-09 | 2014-03-09 | PEMBROLIZUMAB | 02 | N | 280029448 | ETOPOSIDE |
| 280011340 | 280006195 | null | -1 | Palliative (P) | null | 2017-08-10 | BCG Intravesical | N | null | 280029471 | CAPECITABINE + OXALIPLATIN |
| 280011341 | 280006199 | 1.59 | 64.1 | Palliative (P) | 2015-10-12 | 2015-11-03 | Cisplatin + Fluorouracil + RT 5day | null | null | 280029476 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280011342 | 280009250 | 0 | 94 | Palliative (P) | 2016-12-08 | 2016-12-08 | VINCRISTINE | null | null | 280029535 | IRINOTECAN + VINCRISTINE |
| 280011343 | 280012029 | 1.73 | null | Curative (C) | 2013-09-27 | 2013-11-15 | VIDE | null | null | 280029539 | CISPLATIN + FLUOROURACIL + RT |
| 280011344 | 280006211 | 1.67 | null | Disease modification (D) | 2017-12-05 | 2017-12-09 | PERTUZUMAB + TRASTUZUMAB | N | null | 280029556 | ENZALUTAMIDE |
| 280011345 | 280006217 | 1.58 | null | Palliative (P) | 2014-06-29 | 2014-06-30 | Cyclophosphamide + Topotecan | 02 | Y | 280029560 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280011346 | 280010715 | 1.6 | null | Palliative (P) | 2016-08-17 | 2016-09-05 | Cisplatin + Fluorouracil + RT 5day | null | null | 280029571 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280011347 | 280006223 | 1.75 | 88 | Palliative (P) | 2016-06-02 | 2016-06-02 | DABRAFENIB + TRAMETINIB | N | N | 280029584 | VIDE |
| 280011348 | 280006227 | 1.67 | 70.4 | Neo-adjuvant (N) | 2017-04-12 | 2017-04-13 | Folfirinox | 2 | N | 280029599 | DACARBAZINE |
| 280011349 | 280006228 | 1.78 | null | Curative (C) | 2018-03-21 | 2018-05-14 | IPM | null | null | 280029608 | DOCETAXEL |
| 280011350 | 280006234 | 1.65 | 84.7 | Palliative (P) | 2016-12-05 | 2016-12-05 | Cisplatin + Etoposide po&iv 3 day | N | N | 280029631 | RITUXIMAB |